Articles | Open Access | DOI: https://doi.org/10.37547/TAJMSPR/Volume02Issue09-19

inical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection

Nasirova Zebiniso Azizovna , Samarkand State Medical Institute, Samarkand, Uzbekistan
Negmadjanov Bahodur Boltaevich , Samarkand State Medical Institute, Samarkand, Uzbekistan

Abstract

Effective and safe contraceptive methods not only prevent unplanned pregnancies and their
termination, but also make it possible to fully restore the mother's body after surgery to carry out the
necessary pre-pregnancy preparation. The goal of the study was to evaluate the clinical outcome of
postplacental administration of Cu T 380 A in women during a caesarean section. The study was
conducted at Samarkand Maternity Hospital No. 2 to assess the clinical outcome of postplacental
administration of Cu T 380 A in women during caesarean section. The present study showed that there
were no serious complications and only minor side effects such as pain, fever, bleeding and irregular
bleeding, which were observed only in some women during the hospital stay and the control visit in
the first 6 months. The determination of vaginal BMW tendrils was made possible in 72.12% of women
during the control visit after 6 weeks. The visibility of the tendrils increased over time and after 6
months they were seen in 90.81% of cases. Exposure frequency was 2 cases (4%) and another 2 women
(4%) required removal of the PMTCT for various reasons, resulting in a 92.3% retention rate six months
after contraception. No cases of pregnancy were registered. Post-placental introduction of BIC Cu T
380 A during a C-section is a practical, convenient, safe, effective and acceptable contraceptive
method.

Keywords

Сlinical results,, BIC Cu T 380 A

References

An A.V., Pakhomova J.E., Maternal lethality

after Caesarean section. Problems of

Reproduction No. 3, 2010; pp.83-86.

Ayupova F.M., Khamdamova M.T. Clinical

aspects of the use of copper-containing

intrauterine devices // Uzbekiston Tibbiet

Journalist. -2010. № 6. 59-64.

Dikke G.B. LARC-methods of first choice in

prevention of unwanted pregnancy and

repeated abortion // Pharmatek. 2013. №.

p. 8-13.

Barbosa RM, et al. Differences in the

Access to Sterilization between Women

Living and Not Living with HIV: Results

from the GENIH Study, Brazil PLoS One

Brunson M. R. et al. Postpartum

contraception: and effectiveness in a large

universal healthcare system //American

journal of obstetrics and gynecology. 2017.

Т. 217. №. 1. Pp. 55. e1-55. e9.

Garcia G. et al. Trends and disparities in

postpartum sterilization after cesarean

section, 2000 through 2008 //Women's

Health Issues. 2015. Т. 25. №. 6. p. 634-640.

Goldthwaite LM, et al. Postpartum

intrauterine devices: clinical and

programmatic review Am J Obstet Gynecol

- Review.

Haider S. et al. A Novel Approach to

Postpartum Contraception Provision

Combined with Infant Care: A Randomized,

Controlled Trial //Women's Health Issues.

Т. 30. №. 2. p. 83-92

Article Statistics

Copyright License

Download Citations

How to Cite

Nasirova Zebiniso Azizovna, & Negmadjanov Bahodur Boltaevich. (2020). inical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection. The American Journal of Medical Sciences and Pharmaceutical Research, 2(09), 89–95. https://doi.org/10.37547/TAJMSPR/Volume02Issue09-19